Projects funded by the NCN
Assessment of the ability of application of folic acid and/or transferrin as alinkers between conjugates of quantum dots with unsymmetricalbisacridines to enhance their selectivity and cytotoxicity against lung andprostate cancer cells.
2020/37/N/NZ7/01979
Keywords:
antitumor unsymmetrical bisacridines (UAs) quantum dots (QDs) nanoconjugates QD-TM-UAs cytotoxicity cellular response cellular uptake drug delivery.
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ3_1: Cell biology
- NZ7_15: Toxicology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Politechnika Gdańska
woj. pomorskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 19 - announced on 2020-03-16
Amount awarded: 139 998 PLN
Project start date (Y-m-d): 2021-01-14
Project end date (Y-m-d): 2023-01-13
Project duration:: 24 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.